Join us December 2-3 to learn how you can use the latest in silico and in vitro methods for Biological Safety Assessment of medical devices. Engage with industry experts and the Center for Devices and Radiological Health and learn how to use new approaches for risk assessment in the ISO 10993 series, including the newest addition, ISO 10993-23.
At this two-day event you will learn about how to qualify NAMs through CDRH’s Medical Devices Development Tools program, how to perform in silico chemical characterization, and how to use available in vitro methods for assessing irritancy, biocompatibility, pyrogenicity, and thrombogenicity. Don’t miss this chance to network with speakers and have your questions answered during our discussion panels.
Registration for this session is free – sign up below! For more info about the NURA Training program, visit PCRM.org/NURA
Dec. 2, 2021; 10:00 AM ET - 1:30 PM ET
Dec. 3, 2021; 10:00 AM ET - 1:30 PM ET
Jennifer Goode, FDA CDRH
Jeff Brown, PETA Science Consortium International
Ron Brown, Risk Science Consortium
Kelly Coleman, Medtronic
Erin Hill, Institute for In Vitro Sciences
Rose-Marie Jenvert, SenzaGen
Andrew D. Nguyen, PETA Science Consortium International
Mike Wolf, Medtronic